10-Q · May 15, 2026
Hydrofarm reported a significant decline in revenue, falling 29.6% year-over-year to $28.5 million, alongside a steep drop in gross profit margin to 6.4%. Operating losses improved but were still substantial, resulting…
Earnings analysis · 10-Q
HYFM earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
Hydrofarm's Q2 revenue declined 40.9% year over year to $23.2 million, while diluted EPS improved to $(2.23) from $(3.63) but remained materially negative. Free cash flow was approximately $(0.01) million, offering…
Read full summary
Hydrofarm's Q2 revenue declined 40.9% year over year to $23.2 million, while diluted EPS improved to $(2.23) from $(3.63) but remained materially negative. Free cash flow was approximately $(0.01) million, offering little cushion against $114.4 million of variable-rate Term Loan debt and a forbearance period extended only through August 31, 2026. The company also faces Nasdaq compliance issues involving a $(63) million stockholders' deficit and failure to meet the $1 minimum bid-price requirement, making the overall filing bearish despite improved losses and near-breakeven cash flow.
Reported figures
- Earnings per share
- $-2.23
What stood out
-
Revenue remained sharply lower
Q2 revenue was $23.2 million, down 40.9% year over year from $39.2 million, indicating continued substantial demand and/or market contraction.
-
Loss per share improved
Diluted EPS was $(2.23), an improvement from $(3.63) in the prior-year quarter, although the company remained deeply loss-making.
-
Cash flow approached breakeven
Free cash flow was approximately $(0.01) million, substantially better than the $(7.78) million outflow reported in Q1 2026 and roughly breakeven for the quarter.
-
Debt reduction remains central
The company reported $114.4 million of variable-rate Term Loan debt as of June 30, 2026, highlighting the scale of its debt obligations and exposure to interest costs.
-
No control deficiencies reported
Management stated that disclosure controls were effective as of June 30, 2026, and reported no changes in internal controls that materially affected, or were reasonably likely to materially affect, financial reporting.
What to watch
-
Nasdaq equity compliance failure
As of December 31, 2025, stockholders' deficit was approximately $(63) million versus Nasdaq's $2.5 million minimum equity requirement. The company also stated that the market value of listed securities was below $35 million and that it had recorded a net loss in each of the past three fiscal years.
-
Nasdaq bid-price delisting risk
The company received a July 6, 2026 notice for failing to maintain Nasdaq's $1 minimum closing bid price for 30 consecutive business days. It has a 180-calendar-day compliance period and may face delisting if it cannot restore compliance.
-
Forbearance and interest burden
The Forbearance Period was extended only through August 31, 2026, while the company had $114.4 million of variable-rate Term Loan debt outstanding as of June 30, 2026. A 100-basis-point rate increase would raise annual interest expense by approximately $1.2 million, or $1.1 million after the APP-related debt paydown.
-
Severe revenue contraction
A 40.9% year-over-year revenue decline to $23.2 million, together with approximately $(0.01) million of quarterly free cash flow, leaves limited operating cushion to address debt and liquidity obligations.
Management's outlook
No quantitative revenue or EPS guidance was provided in the 10-Q; outlook was deferred/not provided.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.